Quote | Super Quote
Super Quote   |   Detail Quote   |   Interactive Chart   |   Transaction   |   Related News   |   Related Securities   |   Company Information   |   Dividend Records   |   Short Sell
06669 ACOTEC-B
RTNominal up10.920 +0.520 (+5.000%)
Others

11/10/2021 15:54

Acotec (06669) adds physicians to scientific advisory board

[ET Net News Agency, 11 October 2021] Acotec Scientific Holdings Limited (06669) said
it has expanded its Scientific Advisory Board by inviting four more top physicians, Prof.
Peter Schneider, Dr. Matthew T. Menard, Dr. Sahil A. Parikh, and Prof. Thomas Zeller to
join.
The Scientific Advisory Board will provide guidance to and lead the execution of the
company's global study for below-the-knee (BTK) drug-coated balloons (DCB) products
indication expansion in the U.S. and Europe for the purpose of registration with U.S. Food
and Drug Administration (FDA) in the U.S. Meanwhile, the Scientific Advisory Board will
also provide input and feedback to guide the company's new product development in
peripheral intervention space and will support the company's physician education both in
China and in global market. (RC)

Remark: Real time quote last updated: 21/01/2022 17:59
  Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service
A Member of HKET Holdings
Customer Service Hotline:(852) 2880 7004     Customer Service Email:cs@etnet.com.hk
Copyright 2022 ET Net Limited. http://www.etnet.com.hk ET Net Limited, HKEx Information Services Limited, its Holding Companies and/or any Subsidiaries of such holding companies, and Third Party Information Providers endeavour to ensure the availability, completeness, timeliness, accuracy and reliability of the information provided but do not guarantee its availability, completeness, timeliness, accuracy or reliability and accept no liability (whether in tort or contract or otherwise) any loss or damage arising directly or indirectly from any inaccuracies, interruption, incompleteness, delay, omissions, or any decision made or action taken by you or any third party in reliance upon the information provided. The quotes, charts, commentaries and buy/sell ratings on this website should be used as references only with your own discretion. ET Net Limited is not soliciting any subscriber or site visitor to execute any trade. Any trades executed following the commentaries and buy/sell ratings on this website are taken at your own risk for your own account.